Anagrelide platelet‐lowering effect is due to inhibition of both megakaryocyte maturation and proplatelet formation: insight into potential mechanisms

Publisher： John Wiley & Sons Inc

E-ISSN： 1538-7836|13|4|631-642

ISSN： 1538-7933

Source： JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol.13, Iss.4, 2015-04, pp. : 631-642

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effect of Anagrelide on Platelet Coagulant Function in Patients with Essential Thrombocythemia

By  

Acta Haematologica, Vol. 118, Iss. 4, 2007-11 ,pp. : 215-218

Karger

Access to resources Recommend Favorite

Distinct localizations and roles of non‐muscle myosin II during proplatelet formation and platelet release

By  

JOURNAL OF THROMBOSIS AND HAEMOSTASIS, Vol. 13, Iss. 5, 2015-05 ,pp. : 851-859

John Wiley & Sons Inc

Access to resources Recommend Favorite

Potential Benefits of Ticagrelor beyond Platelet Inhibition

By  

Cardiology, Vol. 125, Iss. 1, 2013-04 ,pp. : 31-33

Karger

Access to resources Recommend Favorite

Blood pressure‐lowering effects of propofol or sevoflurane anaesthesia are not due to enhanced nitric oxide formation or bioavailability

By  

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (ELECTRONIC), Vol. 79, Iss. 6, 2015-06 ,pp. : 1030-1033

John Wiley & Sons Inc

Access to resources Recommend Favorite

The role of extracellular matrix stiffness in megakaryocyte and platelet development and function

By  

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 93, Iss. 3, 2018-03 ,pp. : 430-441

John Wiley & Sons Inc

Access to resources Recommend Favorite